24 Mar 2014
Clariant's Annual General Meeting – Shareholders Approve All Agenda Items
- Distribution of CHF 0.36 per share from capital contribution reserves approved
- 2013 Compensation Report approved on a consultative basis
- All members of the Board of Directors reelected
- Approval of all agenda items resulting from the early implementation of the Ordinance against Excessive Compensation (“OaEC”)
Muttenz, March 24, 2014 - At today's Annual General Meeting in Basel, the shareholders of Clariant AG, a world leader in specialty chemicals, approved all agenda items and proposals put forward by the Board of Directors. The meeting was attended by 516 shareholders and shareholder representatives accounting for 169 039 978 shares or around 51 % of the share capital of Clariant.
Hariolf Kottmann, CEO, commented: “We expect full-year sales growth in local currencies in the low to mid-single-digit range and a further improvement in the EBITDA margin before exceptional items in 2014 compared to financial year 2013. We are maintaining our target to become one of the leading specialty chemicals companies by 2015.”
The Annual General Meeting approved the Annual Report as well as the Group’s Consolidated Financial Statements for the financial year 2013 with 99.30 % of the votes in favor. The 2013 Compensation Report was also approved on a consultative basis with 79.61 % of the votes. The members of the Board of Directors and the Executive Committee were discharged with 97.52 % of the votes. In addition, the Annual General Meeting approved the appropriation of the accumulated profit for 2013 with 99.39 % of the votes in favor, as well as the distribution of reserves from capital contributions of CHF 0.36 per share with 99.43 % of the votes.
All members of the Board of Directors were reelected for one year by a large majority, as was the Chairman of the Board of Directors, Rudolf Wehrli. PricewaterhouseCoopers AG was confirmed as the auditor for 2014.
To ensure early implementation of the “OaEC”, Clariant’s Board of Directors proposed comprehensive changes to the Articles of Association to the Annual General Meeting, which were all approved by a majority.
The proposal for overall compensation of the Board of Directors for the period between the 2014 and 2015 Annual General Meetings was approved with 81.86 % of the votes, as was the overall compensation of the Executive Committee for financial year 2015, with 82.26 % of the votes.
NB:
The speeches by Chairman of the Board of Directors Rudolf Wehrli and CEO Hariolf Kottmann along with the minutes of the Annual General Meeting are available under “Annual General Meeting 2014” in the “Investors” area at www.clariant.com.
Reader enquiries
Clariant International Ltd
Rothausstrasse 61
4132 Muttenz 1
Switzerland
Notes for editors
Clariant is a globally leading specialty chemicals company, based in Muttenz near Basel/Switzerland. On December 31, 2013 the company employed a total workforce of 18,099. In the financial year 2013, Clariant recorded sales of CHF 6.076 billion for its continuing businesses. The company reports in four business areas: Care Chemicals, Catalysis & Energy, Natural Resources, and Plastics & Coatings. Clariant’s corporate strategy is based on four pillars: managing businesses for profitability, research & development and innovation, growth in emerging markets, and repositioning of the portfolio.
Related images
CEO Hariolf Kottmann wants to position Clariant in the group of leading specialty chemicals companies by 2015.
(Photo: Clariant)
Editorial enquiries
Kai Rolker
Clariant International Ltd
Claudia Kamensky
Clariant International Ltd
claudia.kamensky@clariant.com
Ulrich Steiner
Investor Relations
Clariant International Ltd
Siegfried Schwirzer
Investor Relations
Clariant International Ltd
Also available in